Origins, structures and functions of circulating DNA in oncology, Cancer Metastasis Rev, vol.35, issue.3, pp.347-376, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02299112
Circulating nucleic acids (CNAs) and cancer -a survey, Biochim. Biophys. Acta, vol.1775, issue.1, pp.181-232, 2007. ,
Presence of fetal DNA in maternal plasma and serum, Lancet Lond. Engl, vol.350, issue.9076, pp.485-487, 1997. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci. Transl. Med, vol.6, issue.224, pp.224-248, 2014. ,
Do circulating tumor cells, exosomes and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology, J. Mol. Diagn. JMD, vol.17, issue.3, pp.209-224, 2015. ,
Modifications des caractèresà la suite de greffes intervariétales chez le Solanum melongena, CR Acad. Sci. Paris, vol.255, pp.361-363, 1962. ,
Cytoplasmic localization of deoxyribonucleic acid in Allium cepa, Nature, vol.195, pp.1115-1116, 1962. ,
Cytoplasmic deoxyribonucleic acid, Int. Rev. Cytol, vol.18, pp.223-247, 1965. ,
Nucleic acids spontaneously released by living frog auricles, Biochem. J, vol.128, issue.3, pp.100-101, 1972. ,
Prehistory of the notion of circulating nucleic acids in plasma/serum (CNAPS): birth of a hypothesis, Ann. NY Acad. Sci, vol.1075, pp.10-20, 2006. ,
The virtosome-a novel cytosolic informative entity and intercellular messenger, Cell Biochem. Funct, vol.28, issue.7, pp.529-538, 2010. ,
Effect of exogenous DNA on acid deoxyribonuclease activity in intact roots of Vicia faba L, Ann. Bot, vol.38, issue.3, pp.701-704, 1974. ,
The origin and properties of extracellular DNA: from PAMP to DAMP, Clin. Immunol. Orlando Fla, vol.144, issue.1, pp.32-40, 2012. ,
Proteins involved in binding and cellular uptake of nucleic acids, Biochemistry (Mosc.), vol.71, issue.6, pp.583-596, 2006. ,
Extracellular nucleic acids, BioEssays, vol.29, issue.7, pp.654-667, 2007. ,
Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res, vol.24, issue.6, pp.766-769, 2014. ,
Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients, Ann. NY Acad. Sci, vol.1022, pp.221-227, 2004. ,
Circulating nucleic acids in blood of healthy male and female donors, Clin. Chem, vol.51, issue.7, pp.1317-1319, 2005. ,
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles, Cell. Mol. Life Sci. CMLS, vol.68, issue.16, pp.2667-2688, 2011. ,
Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content, Expert Opin. Biol. Ther, vol.12, pp.141-153, 2012. ,
Initial degradation of deoxyribonucleic acid after injection in mammals, Cancer Res, vol.25, issue.6, pp.877-883, 1965. ,
The clearance and localization of nucleic acids by New Zealand and normal mice, Clin. Exp. Immunol, vol.12, issue.4, pp.465-476, 1972. ,
Kinetics and mechanisms for removal of circulating single-stranded DNA in mice, J. Exp. Med, vol.147, issue.3, pp.684-699, 1978. ,
Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet, vol.64, issue.1, pp.218-224, 1999. ,
High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing, Clin. Chem, vol.59, issue.8, pp.1228-1237, 2013. ,
Plasma and urine DNA levels are related to microscopic hematuria in patients with bladder urothelial carcinoma, Clin. Biochem, vol.49, pp.1274-1277, 2016. ,
The potential use of urine cell free DNA as a marker for cancer, Expert Rev. Mol. Diagn, vol.16, issue.12, pp.1283-1290, 2016. ,
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study, Gene, vol.590, issue.1, pp.142-148, 2016. ,
Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice, PLoS ONE, vol.4, issue.12, p.8474, 2009. ,
Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to upregulated apoptosis, Am. J. Pathol, vol.175, issue.1, pp.97-106, 2009. ,
Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: methodological aspects, Eur. J. Clin. Chem. Clin. Biochem, vol.31, issue.11, pp.793-797, 1993. ,
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin, Biol. Pharm. Bull, vol.25, issue.6, pp.695-704, 2002. ,
Methylated cell-free DNA in vitro and in vivo, Circulating Nucleic Acids in Plasma and Serum. Gahan PB, pp.185-194, 2010. ,
Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease, PLoS ONE, vol.6, issue.7, p.22659, 2011. ,
Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance, Clin. Exp. Immunol, vol.90, issue.1, pp.56-62, 1992. ,
Fetal DNA clearance from maternal plasma is impaired in pre-eclampsia, Clin. Chem, vol.48, issue.12, pp.2141-2146, 2002. ,
Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo, Clin. Chem, vol.57, issue.4, pp.633-636, 2011. ,
Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise, J. Appl. Physiol, vol.117, issue.2, pp.119-130, 2014. ,
Circulating mutant DNA to assess tumor dynamics, Nat. Med, vol.14, issue.9, pp.985-990, 2008. ,
Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise, Eur. J. Appl. Physiol, vol.110, issue.4, pp.695-701, 2010. ,
Time of sampling is crucial for measurement of cell-free plasma DNA following acute aseptic inflammation induced by exercise, Clin. Biochem, vol.43, pp.1368-1370, 2010. ,
Cell-free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining, Clin. Chem, vol.52, issue.9, pp.1820-1824, 2006. ,
Fetal DNA in maternal plasma: emerging clinical applications, Obstet. Gynecol, vol.98, issue.3, pp.483-490, 2001. ,
Population pharmacokinetics I: background, concepts and models, Ann. Pharmacother, vol.38, issue.10, pp.1702-1706, 2004. ,
Basic concepts in population modeling, simulation and model-based drug development-part 2: introduction to pharmacokinetic modeling methods, CPT Pharmacomet. Syst. Pharmacol, vol.2, p.38, 2013. ,
Basic concepts in population modeling, simulation and model-based drug development, CPT Pharmacomet. Syst. Pharmacol, vol.1, p.6, 2012. ,
A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment, Ann. Oncol, vol.25, issue.1, pp.41-56, 2014. ,
Modeling C-reactive protein kinetic profiles for use as a clinical prediction tool in patients with Staphylococcus aureus bacteremia, Biomark. Med, vol.9, issue.10, pp.947-955, 2015. ,
, , 2012.
Some considerations as to the determination and significance of biologic half-life, J. Pharm. Sci, vol.60, issue.4, pp.624-626, 1971. ,
The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation, Stat. Med, vol.31, issue.30, pp.4280-4295, 2012. ,
Plasma terminal half-life, J. Vet. Pharmacol. Ther, vol.27, issue.6, pp.427-439, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00517570
Therapy control in oncology by circulating nucleosomes, Ann. NY Acad. Sci, vol.1022, pp.211-216, 2004. ,
Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small-cell lung cancer, Clin. Cancer Res, vol.10, pp.5981-5987, 2004. ,